|
|
||||||||||||||
|
|
|||||||||||||||
EXTENDED REPORT |
1 Immuno-Rhumatologie, Lapeyronie Hosp, Montpellier, France
2 Rheumatic diseases, University Hosp, Maastricht, Netherlands
3 Rheumatology and Research Centre, University of Medicine, Cluj-Napoca, Romania
4 Rheumatology, Leiden University Medical Centre, Leiden, Netherlands
5 Rheumatology B, Cochin Hospital, Paris, France
6 Rheumatology, Academic Unit of Musculoskeletal diseases, Leeds, United Kingdom
7 Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy
8 Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands
9 Rheumatology, Karolinska Hospital, Stockholm, Sweden
10 Internal Medicine III, Medical University, Vienna, Austria
11 Rheumatology, Hospital La Paz, Madrid, Spain
12 Rheumatology Q, University Hospital, Herlev, Denmark
13 ARC Unit, Manchester University, Manchester, United Kingdom
14 Rheumatology, Cerrahpasa Medical Faculty, Istanbul, Turkey
Correspondence to:
Correspondence to:
Professor Bernard Combe
Immuno-Rhumatologie, CHU Lapeyronie 34295 Montpellier cedex 5, France; b-combe{at}chu-montpellier.fr
Objective: To formulate EULAR recommendations for the management of early arthritis.
Methods: In accordance with EULARs "standardised operating procedures", the task force pursued an evidence based approach and an approach based on expert opinion. A steering group comprised of 14 rheumatologists representing 10 European countries. The group defined the focus of the process, the target population, and formulated an operational definition of "management". Each participant was invited to propose issues of interest regarding the management of early arthritis or early rheumatoid arthritis. Fifteen issues for further research were selected by use of a modified Delphi technique. A systematic literature search was carried out. Evidence was categorised according to usual guidelines. A set of draft recommendations was proposed on the basis of the research questions and the results of the literature search.. The strength of the recommendations was based on the category of evidence and expert opinion.
Results: 15 research questions, covering the entire spectrum of "management of early arthritis", were formulated for further research; and 284 studies were identified and evaluated. Twelve recommendations for the management of early arthritis were selected and presented with short sentences. The selected statements included recognition of arthritis, referral, diagnosis, prognosis, classification, and treatment of early arthritis (information, education, non-pharmacological interventions, pharmacological treatments, and monitoring of the disease process). On the basis of expert opinion, 11 items were identified as being important for future research.
Conclusions: 12 key recommendations for the management of early arthritis or early rheumatoid arthritis were developed, based on evidence in the literature and expert consensus.
Abbreviations: ACR, American College of Rheumatology; ASPIRE, Active Controlled Study of Patients Receiving Infliximab for Treatment of Rheumatoid Arthritis; DAS, disease activity score; DMARD, disease modifying antirheumatic drug; ESCISIT, European Standing Committee for International Clinical Studies Including Therapeutics; EULAR, European League Against Rheumatism; RCT, randomised controlled trial; TEMPO, Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes; TICORA, Tight Control for Rheumatoid Arthritis study; TNF, tumour necrosis factor
Keywords: early arthritis; rheumatoid arthritis; management; diagnosis
This article has been cited by other articles:
![]() |
H Makinen, P Hannonen, and T Sokka Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann Rheum Dis, July 1, 2008; 67(7): 1052 - 1053. [Full Text] [PDF] |
||||
![]() |
N. Adib, K. Hyrich, J. Thornton, M. Lunt, J. Davidson, J. Gardner-Medwin, H. Foster, E. Baildam, L. Wedderburn, and W. Thomson Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study Rheumatology, July 1, 2008; 47(7): 991 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
E H S Choy, C M Smith, V Farewell, D Walker, A Hassell, L Chau, D L Scott, and for the CARDERA (Combination Anti-Rheumatic Drugs Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis Ann Rheum Dis, May 1, 2008; 67(5): 656 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S W Syversen, P I Gaarder, G L Goll, S Odegard, E A Haavardsholm, P Mowinckel, D van der Heijde, R Landewe, and T K Kvien High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study Ann Rheum Dis, February 1, 2008; 67(2): 212 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, A J Peeters, M V van Krugten, F C Breedveld, B A C Dijkmans, and C F Allaart Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score Ann Rheum Dis, February 1, 2008; 67(2): 266 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L Hyrich Patients with suspected rheumatoid arthritis should be referred early to rheumatology BMJ, January 26, 2008; 336(7637): 215 - 216. [Full Text] [PDF] |
||||
![]() |
M F Bakker, J W G Jacobs, S M M Verstappen, and J W J Bijlsma Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii56 - iii60. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. M. Vliet Vlieland Non-drug care for RA is the era of evidence-based practice approaching? Rheumatology, September 1, 2007; 46(9): 1397 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Finckh and M. H. Liang Anti-Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze Ann Intern Med, June 5, 2007; 146(11): 816 - 817. [Full Text] [PDF] |
||||
![]() |
D. L. Scott Early rheumatoid arthritis Br. Med. Bull., May 31, 2007; (2007) ldm011v1. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |